Study Stopped
Lack of participants
Hormonal and Metabolic Aspects of Endoscopic Sleeve Gastroplasty
1 other identifier
interventional
N/A
1 country
1
Brief Summary
The investigators of the study want to investigate the complex interactions between glucose metabolism, food intake/weight loss, and different appetite regulating hormones after ESG in comparison with conventional laparoscopic sleeve gastrectomy (LSG).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Jun 2020
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 5, 2020
CompletedFirst Submitted
Initial submission to the registry
June 19, 2020
CompletedFirst Posted
Study publicly available on registry
June 30, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2023
CompletedSeptember 5, 2021
August 1, 2021
1.8 years
June 19, 2020
August 31, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Changes in ghrelin (pg/ml)
Changes in ghrelin after a solid meal test compared before and after surgery
240 minutes
Secondary Outcomes (1)
Changes in gut hormone response before and after sugery (pmol/L)
240 minutes
Study Arms (2)
Endoscopic sleeve gastroplasity operated patients
OTHERFour test days, two days before surgery, one test day three months after surgery and one test day one year after surgery
Laparoscopic sleeve gastrectomy operated patients
OTHERFour test days, two days before surgery, one test day three months after surgery and one test day one year after surgery
Interventions
Four-hour solid mixed meal test
Four-hour solid mixed meal test
Eligibility Criteria
You may qualify if:
- Age \> 18 years
- Scheduled for endoscopic or laparoscopic sleeve at Hvidovre Hospital
- HbA1c \< 48 mmol/mol before surgery, and no history of diabetes
- BMI\<45
You may not qualify if:
- Pregnancy or breast feeding
- Medication affecting the planned examinations
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Endocrinology, Hvidovre University Hospital
Copenhagen, Hvidovre, 2650, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 19, 2020
First Posted
June 30, 2020
Study Start
June 5, 2020
Primary Completion
April 1, 2022
Study Completion
April 1, 2023
Last Updated
September 5, 2021
Record last verified: 2021-08